MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality

Background. MORDOR I found that 2 years of biannual mass azithromycin administration reduced post-neonatal childhood mortality by 18% in Niger. Over time, this benefit could increase with each distribution or wane due to antibiotic resistance. Here in MORDOR II, we treated communities in both arms f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Keenan, Jeremy D., Arzika, Ahmed M., Maliki, Ramatou, Boubacar, Nameywa, Elh Adamou, Sanoussi, Moussa Ali, Maria, Cook, Catherine, Lebas, Elodie, Lin, Ying, Ray, Kathryn J., O’Brien, Kieran S., Doan, Thuy, Oldenburg, Catherine E., Callahan, E. Kelly, Emerson, Paul M., Porco, Travis C., Lietman, Thomas M.
Formato: Artigo
Idioma:Inglês
Publicado em: Massachusetts Medical Society 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512890/
https://ncbi.nlm.nih.gov/pubmed/31167050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1817213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados